Unterschiede
Hier werden die Unterschiede zwischen zwei Versionen angezeigt.
Beide Seiten der vorigen Revision
Vorhergehende Überarbeitung
|
|
crocus_sativus_l [2017/10/27 09:05] andreas |
crocus_sativus_l [2021/12/08 22:39] (aktuell) andreas |
| |
---- | ---- |
| |
| "A specification for high-quality saffron of > 20% crocins, > 6% pic-rocrocin and not less than 0.3% of volatiles, calculated as sum of safranal, isophorone and ketoisophorone, was developed... Saffron extracts and crocetin had a clear binding capacity at the PCP bindingside of the NMDA receptor and at the σ1 receptor, while the crocins and picrocrocin were not effective." \\ |
| [Lechtenberg, Matthias, et al. "Quality and functionality of saffron: quality control, species assortment and affinity of extract and isolated saffron compounds to NMDA and σ1 (sigma-1) receptors." Planta medica 74.07 (2008): 764-772] |
| |
"Saffron is the dried stigma of Crocus sativus L. and has been used for centuries in traditional medicine mainly for its healing properties... Recent phytochemistry and pharmacological experiments have indicated that crocin and safranal, the major active ingredients of saffron, exert important actions, such as antioxidant, anti-tumor, anti-diabetic, anti-inflammatory and anti-atherosclerotic. Unfortunately, the vast majority of those data derive from in vitro studies, whereas a limited number of in vivo experiments support the aforementioned effects." \\ | "Saffron is the dried stigma of Crocus sativus L. and has been used for centuries in traditional medicine mainly for its healing properties... Recent phytochemistry and pharmacological experiments have indicated that crocin and safranal, the major active ingredients of saffron, exert important actions, such as antioxidant, anti-tumor, anti-diabetic, anti-inflammatory and anti-atherosclerotic. Unfortunately, the vast majority of those data derive from in vitro studies, whereas a limited number of in vivo experiments support the aforementioned effects." \\ |